Monkeypox
📧 Sign up to get email alerts when something new happens for Monkeypox.
Sign up freeTop drugs studied for this disease
-
EMA guidance · 2024-10-25Fostering regulatory collaboration to improve access to mpox medicines
Global regulators discuss knowledge supporting mpox medicine development and approval. The aim is to improve access to mpox treatments.
-
EMA guidance · 2022-08-19EMA’s Emergency Task Force advises on intradermal use of Imvanex / Jynneos against monkeypox
EMA’s Emergency Task Force recommends intradermal administration of Imvanex/Jynneos for monkeypox to optimize dose use and supply during out…
-
EMA guidance · 2022-07-27EMA response to the monkeypox public health emergency
EMA outlines its response and actions in relation to the monkeypox public health emergency, including regulatory considerations and support …
-
EMA guidance · 2022-06-28Monkeypox: EMA starts review for Imvanex
EMA initiates a review of Imvanex in relation to Monkeypox to assess available evidence and potential regulatory actions.